Evelyne Alves Santos

Evelyne Alves Santos

Auto-generated profile, based on publicly available information

Evelyne Alves Santos

Department of Cell Biology and Development, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2011 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
David da RochaDavid da Rocha
David da Rocha
ASAna C. G. de Souza
Ana C. G. de Souza
JRJackson A. L. C. Resende
Jackson A. L. C. Resende
WSWilson Santos
Wilson Santos
ESEvelyne A. dos Santos
Evelyne A. dos Santos
Vitor ferreiraVitor ferreira
Vitor ferreira
A synthetic method to obtain α- and β-pyran naphthoquinones 10 and 11 with a hydroxyl substituent on the aromatic ring was developed. Two series of α- and β-pyran naphthoquinones were obtained from the 8-hydroxy-lawsone, and their anticancer properties were evaluated against four tumor cell lines. In general, the new compounds displayed good activity, possibly indicating that these compounds have increased pro-oxidant capacity. The 9-hydroxy-α-lapachone and 7-hydroxy-β-lapachone analogues of the natural products α-lapachone and β-lapachone were successfully produced by this methodology.

16 April 2015 in Journal of Natural Products
Verified
Journal Article
Closed access
ESEvelyne A. Santos
Evelyne A. Santos
AQAmanda L. Quintela
Amanda L. Quintela
EFElthon G. Ferreira
Elthon G. Ferreira
TSThiciana S. Sousa
Thiciana S. Sousa
FPFrancisco das Chagas Lima Pinto
Francisco das Chagas Lima Pinto
LCLeticia Costa-Lotufo
Leticia Costa-Lotufo

10 January 2017 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
AAAndrew J. Ambrose
Andrew J. Ambrose
ESEvelyne A. Santos
Evelyne A. Santos
PJPaula C. Jimenez
Paula C. Jimenez
DRDanilo D. Rocha
Danilo D. Rocha
DWDiego Veras Wilke
Diego Veras Wilke
JCJames J. La Clair
James J. La Clair

1 January 2015 in Journal of Complementary Medicine Research
Verified
Journal Article
Open access
PDF file
ESEvelyne Simes
Evelyne Simes
ESEvelyne Alves Santos
Evelyne Alves Santos
MAMaria Abreu
Maria Abreu
JSJurandy Do Nascimento Silva
Jurandy Do Nascimento Silva
NNNrcia Nunes
Nrcia Nunes
PFPaulo Michel Pinheiro Ferreira
Paulo Michel Pinheiro Ferreira
Lippia microphylla Cham. (Verbenaceae) is an endemic underexploited Brazilian vegetal. This work reviewed the biological potentialities of Lippia microphylla, emphasizing the properties of essential oils (EOs) and analyzed scientific indicators about genus Lippia and L. microphylla. Databases from 1948 to the present were searched and a software (vantage point 7.1) associated with Derwent Innovation Index was used to identify the indicators of the genus Lippia, and biological activities and compounds in the L. macrophylla species. Ethnopharmacological records report use of L. microphylla leaves to treat gastrointestinal disorders, influenza, bronchitis, cough, nasal congestion, and sinusitis during vaporization, whose aromatic volatile oils are rich in monoterpenes, especially cineole, terpineol, and thymol. Other EOs have larvicidal activity on Aedes aegypti larvae, and antifungal, antibacterial and cytotoxic and antitumor action on human and murine cancer cells. Brazil is the country with more articles about Lippia species, but it deposited only 9 patents since 1993. Most of the publications about L. microphylla are concentrated in food and chemical sciences. This bioprospection helps to choice areas of interest for capital investment and to give support for Brazilian Institutions to establish cooperation and improve technological impact at the point of view of creation and innovation.

25 September 2012 in RSC Advances
Verified
Journal Article
Closed access
PDF file
VCVinícius Campos
Vinícius Campos
ESEvelyne A. dos Santos
Evelyne A. dos Santos
Vitor ferreiraVitor ferreira
Vitor ferreira
RMRaquel C. Montenegro
Raquel C. Montenegro
MSMaria Cecília B.V. De Souza
Maria Cecília B.V. De Souza
ACAnna C. Cunha
Anna C. Cunha
A novel series of carbohydrate-based 1,2-naphthoquinones 13a–c and their substituted phenylhydrazono derivatives 14a–l were synthesized and evaluated for cytotoxicity against HL-60, MDA-MB435, HCT-116 and SF-295 cancer cell lines. The compounds 9a–c showed the best cytotoxicity profile (IC50 below 2 μM) against HL-60 and MDA-MB 435 human cells, while the hydrazone derivative 14i (IC50 HL-60 1.65 μM) was selective for leukemia when compared to the reference drug doxorubicin. None of the compounds exhibited lytic effects against mouse erythrocytes. Characterization of all compounds was confirmed by one- and two-dimensional NMR techniques (1H, 13C-APT, COSY-1H × 1H and HETCOR 1JCH) and by elemental analysis.

1 October 2019 in Biochemical Pharmacology
Verified
Journal Article
Closed access
LALarissa Costa de Almeida
Larissa Costa de Almeida
ABAnelize Bauermeister
Anelize Bauermeister
PRPaula Rezende-Teixeira
Paula Rezende-Teixeira
ESEvelyne Alves dos Santos
Evelyne Alves dos Santos
LMLuiz Alberto Beraldo de Moraes
Luiz Alberto Beraldo de Moraes
LCLeticia Costa-Lotufo
Leticia Costa-Lotufo